Peptide record

TPDB12353

Antibacterial Anticancer Hemolysis Toxicity standard
11 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB12353
Antibacterial Anticancer Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 Peptipedia PD_Hemolysis
standard
No
A 11-aa standard natural multi-activity (Antibacterial, Anticancer, Hemolysis, and other sources) peptide sequence curated from AntiBP3, Peptipedia, and PD_Hemolysis, with an available 3D structural model.
Sequence
GRWRWWWRWRI
Physicochemical Analysis
C87H114N28O12
ANDCEQHLKMFPSTYV
W
1744.04
12.88
4
0
6
+4
-6.31
-1.673
35.45
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
27500
1576.80
0
Residue Composition
number
0
A
4
R
0
N
0
D
0
C
0
E
0
Q
1
G
0
H
1
I
0
L
0
K
0
M
0
F
0
P
0
S
0
T
5
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 4 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 1 H: 0 I: 1 L: 0 K: 0 M: 0 F: 0 P: 0 S: 0 T: 0 W: 5 Y: 0 V: 0
Chemical Descriptors
11
C87H114N28O12
1744.04
12.88
+4
-6.31
-1.673
Evidence Records 5 records
Evidence 1 Activity

Activity

10% Hemolysis
Toxicity
32 µM
Hemolytic Cytotoxic
10% Hemolysis | 32 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Therapeutic Potential of Trp-Rich Engineered Amphiphiles by Single Hydrophobic Amino Acid End-Tagging. | ACS Appl Mater Interfaces | 2019
Evidence 2 Activity

Activity

0% Cytotoxicity
Toxicity
32 µM
Cytotoxic
0% Cytotoxicity | 32 | µM | target cell: Human embryonic kidney HEK293T cells

Target

Human embryonic kidney HEK293T cells

Source & Reference

NA
DBAASP
Therapeutic Potential of Trp-Rich Engineered Amphiphiles by Single Hydrophobic Amino Acid End-Tagging. | ACS Appl Mater Interfaces | 2019
Evidence 3 Activity

Activity

10% Cytotoxicity
Toxicity
32 µM
Cytotoxic
10% Cytotoxicity | 32 | µM | target cell: Intestinal Porcine Epithelial Cells IPEC-J2

Target

Intestinal Porcine Epithelial Cells IPEC-J2

Source & Reference

NA
DBAASP
Therapeutic Potential of Trp-Rich Engineered Amphiphiles by Single Hydrophobic Amino Acid End-Tagging. | ACS Appl Mater Interfaces | 2019
Evidence 4 Activity

Activity

10% Hemolysis
Toxicity
32 µM
Hemolytic Cytotoxic
10% Hemolysis | 32 | µM | target cell: Mouse erythrocytes

Target

Mouse erythrocytes

Source & Reference

NA
DBAASP
Optimizing therapeutic efficacy of antifungal peptides via strategic terminal amino acid modification | J Adv Res | 2024
Evidence 5 Hemolysis

Source & Reference

PD_Hemolysis
PD_Hemolysis